(Q53980986)
Statements
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. (English)
Findling RL
1 January 1996
6
3
165-175